Blog

December 12, 2023December 12, 2023

MiSight® 1 day Six-Year Study Findings Verified, Companion Video Offers Highlights for ECPs

A new peer-reviewed paper has further validated the myopia control efficacy of CooperVision’s innovative MiSight^® 1 day contact lenses. Published in Ophthalmic and Physiological Optics, the journal of the UK College of Optometrists, Six-Year Cumulative Treatment Effect and Treatment Efficacy of a Dual Focus Myopia Control Contact Lens (Chamberlain P, et al) details findings and insights from the ground-breaking study—the longest investigation of its kind. The paper is available via open access here.

In addition, the company has released a companion video interview with two of the paper’s co-authors and CooperVision R&D leaders: Senior Director of Research Programs Paul Chamberlain, BSc (Hons) and Research Fellow Arthur Bradley, PhD. Hosted by Myopia Profile’s Kate Gifford, PhD and Paul Gifford, PhD, it describes the study methodologies, outcomes, and clinical applications.

View the video HERE.

“We remain committed to provide eye care professionals with high quality evidence to answer important questions on the long-term impact of myopia management with MiSight® 1 day” said Chamberlain, CooperVision. “The rigorous, multi-center study design, unequaled investigation timeframe, and clear outcomes have strengthened prescribing confidence for this unique, effective optical intervention to slow the progression of myopia. This publication will further reinforce those evidence-based behaviors, as the global eye care community collectively addresses the childhood myopia epidemic.”

The paper describes that in the absence of a second phase control group for ethical reasons, prior myopia progression, emmetropic eye growth, and delay in time to progress analysis methods can be used to estimate myopia control efficacy. MiSight^® 1 day slowed eye growth to less than half that observed in untreated children, paralleling modelled rates of emmetropic eye growth. Moreover, when myopic children begin treatment with MiSight^® 1 day between the ages of 8-12, the probability of > 0.3mm eye growth occurring within one to three years decreased by 95%.

The paper also confirms the value of pursuing myopia control treatment for young children using MiSight^® 1 day. Early intervention provides opportunity for greater myopia control potential, which may help reduce reliance on vision correction, limit changes in prescriptions between appointment visits in support of developmental and educational milestones, lessening myopia’s impact on future ocular health.

Now prescribed in more than 30 countries, CooperVision’s MiSight^® 1 day is the first and only soft contact lens approved by the FDA* to both correct vision and slow the progression of myopia in children aged 8-12 at the initiation of treatment. Additionally, it was the first Chinese NMPA-approved soft contact lens with an indication relating to slowing the progression of axial length in patients who at initiation are 8-12 years old and have a refraction of -0.75 D to -4.00 D with ≤ 0.75 diopters of astigmatism. It also has the CE mark designation. The company also offers a range of orthokeratology contact lens designs and spectacle lenses with Diffusion Optics Technology^™ for myopia management.

Click HERE for the full press release.

For more related content on Optik Now, click HERE.

December 11, 2023December 11, 2023

OGS Earns Four-Star Rating from Charity Navigator

Optometry Giving Sight (OGS) announces that its strong financial health and ongoing accountability and transparency have earned a Four-Star Rating from Charity Navigator.

This rating designates Optometry Giving Sight as an official “Give with Confidence” charity, indicating that OGS is using its donations effectively based on Charity Navigator’s criteria.

Charity Navigator is America’s largest and most utilized independent charity evaluator. Since 2001, the organization has been an unbiased and trusted source of information for more than 11 million donors annually.

Charity Navigator analyzes nonprofit performance based on four key indicators, referred to as beacons. Currently, nonprofits can earn scores for the Impact & Results, Accountability & Finance, Culture & Community, and Leadership & Adaptability beacons.

“We are delighted to provide Optometry Giving Sight with third-party accreditation that validates their operational excellence,” said Michael Thatcher, President and CEO of Charity Navigator. “The Four-Star Rating is the highest possible rating an organization can achieve. We are eager to see the good work that OGS is able to accomplish in the years ahead.”

“Our Four-Star Charity Navigator rating is further validation that our supporters can trust our commitment to good governance and financial health,” said OGS Executive Director Lois Schoenbrun, CAE (Ret.), FAAO. “As we work with our partners to eliminate unnecessary vision impairment in the U.S. and around the world, we want our donors to know that we appreciate them and value their trust in us.”

Optometry Giving Sight supports sustainable and scalable optometry-led programs that educate eye care providers locally and enable the establishment and delivery of vision care and eye health to all. In 2023 alone, OGS is funding 21 programs in the U.S. and globally, totaling more than $900,000 USD.

Click HERE for the press release.

For more related content on Optik NOW, click HERE.

December 11, 2023December 11, 2023

FYihealth group Announces Trevor Bartlett as New Chief Operating Officer

FYihealth group adds a new face to its senior leadership team: Trevor Bartlett. Joining as Chief Operating Officer, Bartlett’s extensive background includes experience in large, fast-growing companies such as Sobeys, Rexall, and Giant Tiger. Bartlett will be overseeing FYihealth group’s Operations, Retail Optical, Product, Supply Chain, and Marketing.

“The team is excited to have Trevor join us,” expresses Dr. Alan Ulsifer, CEO and Chair of FYihealth group, “Trevor understands how important our culture is and has been a highly respected and admired leader throughout his career. He exemplifies our organization’s values and operates as a team player and coach. His retail experience will help bring us a new perspective as we continue to expand our market share in Canada and provide essential eye health services to Canadians.”

Bartlett will bring a new “lens” to the FYihealth group business along with his passion for consumers, patients and developing talent. He shared: “I look forward to bringing my retail experiences from food, pharmacy, and general merchandise to the FYihealth group. I have a passion for connecting retail products and services to consumers, ultimately creating a tailored solution unique to them.”

FYihealth group was named one of Canada’s Top Growing Companies in 2022 and 2023 by Globe and Mail’s Report on Business. The addition of Bartlett is part of the organization’s strategy to continue its growth in 2024, with plans to continue its expansion to provide eye care access to more Canadians.

Click HERE for the press release.

For more related content on Optik NOW, click HERE.

December 8, 2023December 8, 2023

opti 2024 Boosts Desire for Lenses

In addition to market players from the contact lens sector at opti 2024, highly customised iris shootings will ensure more focus on the lens. “The opti iris photography offer will inspire our trade show visitors – at the same time, it actively raises awareness of the topic of healthy eyes and contact lenses, because this is where we will continue to step on the pedal together with all market players in the coming years,” says opti Exhibition Director Cathleen Kabashi.

opti 2014, Halle C 3, Kontaktlinsen, Bausch & Lomb, Stand C3.505

Visibility and attention for the topic of contact lenses will be significantly increased at the upcoming opti from January 12-14, 2024. After all, key topics in the industry such as myopia management, an increasing number of presbyopic people, suitable training courses and marketing tools are closely linked to these transparent little helpers.

There are real (sales) opportunities here for the professional world that need to be utilised. In Hall C4, contact lens, care product and machine manufacturers such as MPG&E, Menicon GmbH, CooperVision and other players will be showcasing their respective highlights.

“Lens in focus” – Iris Shoots with an Emotional Impact

In addition to the contact lens manufacturers who will be on site in 2024, the new “Lens in Focus” area could not be more individualised. Using high-resolution photography, one eye will be photographed at a time during special lens shoots in Hall C4, booth C4.341.

After highly complex image processing, an individual, unique iris artwork is created. The photo is gentle on the eyes and safe, as it does not use LED technology. The result: not only a guaranteed eye-catcher and an idea for your own optical business, but also a lasting emotional souvenir of opti 2024 in Munich. Thanks to special effects that can be freely selected, unforgettable masterpieces are created from visitors’ eyes that will stay with them, images that tell stories of life, love, happiness or experiences.

But the indirect message is also crystal clear: our eyes and vision are irreplaceable and deserve to be honoured from all sides at the trade show – including the contact lens side.

Offer for Contact Lens Exhibitors

This highlight, which will be played by opti on all channels before, during and after the trade show, will significantly increase awareness of the area. Cathleen Kabashi: “With the combined expertise of the participating suppliers, this special area will have a magnetic effect.”

Source: opti 2024

December 7, 2023November 16, 2023

Inface Eyewear: Wombat, Casual but Edgy

Inface’s Wombat (model number 9531) is the small, compact newcomer in our titanium rim concept. Casually edgy, and with the possibility of having a lot of attitude or being more discreet depending on your mood and outfit. Wombat is a rectangular rim shape, super light, and designed in titanium materials.

Distributed by COS: canadianoptical.com